Inside USP: Modernizing the Compendia - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Inside USP: Modernizing the Compendia
Industry participation is crucial as USP embarks on far-reaching monograph modernization initiative. This is an online-exclusive article.

Pharmaceutical Technology
Volume 34, Issue 9

Submission of modernization proposals and donor recognition

Parties wishing to support the updating of standards can submit monograph modernization proposals to USP and donate associated reference standards. To maintain consistency with FDA-approved control strategies, USP prefers to receive submissions from manufacturers of FDA-approved products or manufacturers intending to seek FDA approval (the latter category of submissions will be initially considered for publication as a pending standard through USP s Pending Monograph process). Submissions, especially new impurity procedures, from other sources (e.g., contract laboratories, academic institutions, and analytical instrumentation/equipment manufacturers) will be accepted by USP on a case-by-case basis. Additional information about submitting proposals is available at

Recognizing the importance of industry contributions, USP recently expanded its Donor Recognition Program. Under the program, qualifying donors of monographs and reference materials are recognized through a portfolio of options. For example, donors may be recognized in USP publications and at the USP Science & Standards Symposium, formerly known as the Annual Scientific Meeting. In additon, donors may receive complimentary or discounted registrations to the USP Science & Standards Symposium; complimentary workshop registrations; a complimentary print subscription to USP-NF, the Food Chemicals Codex (FCC), or Dietary Supplements Compendium; complimentary registration for an on-site USP Pharmacopeial Education course; one-year, multiple-user license of electronic USP-NF or FCC; and complimentary USP Reference Standards. The expanded program is meant to acknowledge that the development of quality standards is truly a cooperative and collaborative effort. In USP s mission to protect public health through the establishment and maintenance of quality standards, USP appreciates the vital participation of industry.

Proposal review

One of the most important elements of the monograph modernization effort will be the public review of modernization proposals. All proposals will be published in the Pharmacopeial Forum (PF), the vehicle through which USP develops and revises USP-NF standards, and will follow USP s established process for public review and comment. Because any single proposal for modernization has the potential to impact the industry significantly (manufacturers will be required to comply with updated standards upon their effective date), USP would like to emphasize the importance of reviewing submissions to PF and encourages manufacturers to provide comments. More information about the program is available at

Karen A. Russo, PhD, is vice-president, small molecules, at the US Pharmacopeial Convention (USP).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here